Pharmacokinetics of cetirizine in 2- to 6-year-old children. 1995

A Pariente-Khayat, and E Rey, and M C Dubois, and F Vauzelle-Kervroedan, and G Pons, and P D'athis, and I I Murat, and M E Pinelli, and C Saint-Maurice, and G Olive
Département de Pharmacologie Périnatale et Pédiatrique, Hôpital Saint-Vincent de Paul, Université René Descartes, Paris, France.

Eight children (3.84 +/- 1.17 years old) received a single oral 5 mg cetirizine dose (0.32 +/- 0.07 mg.kg-1) as a 10 mg.ml-1 solution, 1.73 (+/- 0.64) hours before a minor surgical intervention (mean duration +/- SD = 0.90 +/- 0.25 h). Seven venous blood samples were collected before administration (t0) and 0.5 h, 1.5 h, 4 h, 8 h, 12 h and 24 h after dosing, and urine samples were collected up to 24 hours after the dose. The mean +/- SD kinetic parameters were: peak plasma level (Cmax) 607 +/- 231 micrograms.l-1 reached in 1.93 +/- 1.39 h (tmax), elimination half-life (t1/2) 5.55 +/- 0.98 h, area under the plasma concentration time curve (AUC0-infinity) 4,772.1 +/- 1,318.4 micrograms.l-1.h, mean residence time (MRT) 8.13 +/- 1.31 h, apparent plasma clearance (Cl/f) 1.27 +/- 0.80 ml.min-1.kg-1, apparent volume of distribution (Vz/f) 0.60 +/- 0.38 l.kg-1. Urinary recovery was 38.4 +/- 9.9% (n = 4) of the dose. Renal clearance was 0.42 +/- 0.10 ml.min-1.kg-1 (n = 6). No influence of age on the cetirizine parameters was evidenced among this group, except for MRT (p < 0.05) which decreases with age. When compared with results in adults, elimination half-life (t1/2) was twice as short and apparent clearance twice as great. These results suggest that a higher dosage b.i.d. may be required in children.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D005445 Flunitrazepam A benzodiazepine with pharmacologic actions similar to those of DIAZEPAM that can cause ANTEROGRADE AMNESIA. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug. Fluridrazepam,Rohypnol,Fluni 1A Pharma,Flunibeta,Flunimerck,Fluninoc,Flunitrazepam-Neuraxpharm,Flunitrazepam-Ratiopharm,Flunitrazepam-Teva,Flunizep Von Ct,Narcozep,RO-5-4200,Rohipnol,Flunitrazepam Neuraxpharm,Flunitrazepam Ratiopharm,Flunitrazepam Teva,RO54200,Von Ct, Flunizep
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Pariente-Khayat, and E Rey, and M C Dubois, and F Vauzelle-Kervroedan, and G Pons, and P D'athis, and I I Murat, and M E Pinelli, and C Saint-Maurice, and G Olive
September 2008, Pediatric emergency care,
A Pariente-Khayat, and E Rey, and M C Dubois, and F Vauzelle-Kervroedan, and G Pons, and P D'athis, and I I Murat, and M E Pinelli, and C Saint-Maurice, and G Olive
November 2013, Journal of intellectual disability research : JIDR,
A Pariente-Khayat, and E Rey, and M C Dubois, and F Vauzelle-Kervroedan, and G Pons, and P D'athis, and I I Murat, and M E Pinelli, and C Saint-Maurice, and G Olive
December 1987, The American journal of occupational therapy : official publication of the American Occupational Therapy Association,
A Pariente-Khayat, and E Rey, and M C Dubois, and F Vauzelle-Kervroedan, and G Pons, and P D'athis, and I I Murat, and M E Pinelli, and C Saint-Maurice, and G Olive
May 2006, Obesity (Silver Spring, Md.),
A Pariente-Khayat, and E Rey, and M C Dubois, and F Vauzelle-Kervroedan, and G Pons, and P D'athis, and I I Murat, and M E Pinelli, and C Saint-Maurice, and G Olive
December 1980, Ceskoslovenska pediatrie,
A Pariente-Khayat, and E Rey, and M C Dubois, and F Vauzelle-Kervroedan, and G Pons, and P D'athis, and I I Murat, and M E Pinelli, and C Saint-Maurice, and G Olive
September 1973, Archives of general psychiatry,
A Pariente-Khayat, and E Rey, and M C Dubois, and F Vauzelle-Kervroedan, and G Pons, and P D'athis, and I I Murat, and M E Pinelli, and C Saint-Maurice, and G Olive
February 1986, Meditsinskaia sestra,
A Pariente-Khayat, and E Rey, and M C Dubois, and F Vauzelle-Kervroedan, and G Pons, and P D'athis, and I I Murat, and M E Pinelli, and C Saint-Maurice, and G Olive
January 2006, International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity,
A Pariente-Khayat, and E Rey, and M C Dubois, and F Vauzelle-Kervroedan, and G Pons, and P D'athis, and I I Murat, and M E Pinelli, and C Saint-Maurice, and G Olive
June 1988, Sbornik lekarsky,
A Pariente-Khayat, and E Rey, and M C Dubois, and F Vauzelle-Kervroedan, and G Pons, and P D'athis, and I I Murat, and M E Pinelli, and C Saint-Maurice, and G Olive
September 2009, Japanese journal of ophthalmology,
Copied contents to your clipboard!